Tag: vapes
-
![Heritage Cannabis (CANN.C) launches new consumer product as global cannabis stocks rally 61% in Q4, 2020]()
Heritage Cannabis (CANN.C) launches new consumer product as global cannabis stocks rally 61% in Q4, 2020
CANN focuses on extraction and the creation of derivative products for recreational and medical consumers.
-
Heritage Cannabis (CANN.C) up hard on Alberta sales news
No cannabis companies splits investors squarely down the middle like Heritage Cannabis (CANN.C). Despite ongoing good news and deals with larger players, a sizable section of the legacy cannabis investing community has just never been able to get on board with the Canadian weedco – until this week. Our Joseph Morton blew the trumpet on…
-
![Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus]()
Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”
-
Heritage Cannabis (CANN.C) is so close profitability, it’s breaking social distancing rules
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate revenue going forward.
-
Heritage Cannabis (CANN.C) to develop vape oil with Sugarbud’s biomass
Heritage is positioning itself to radically expand its sales territory.
-
Heritage Cannabis (CANN.C) acquires Opticann – to create an international medical footprint
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”.
-
![Heritage Cannabis (CANN.C) releases Q2, 2020 financials]()
Heritage Cannabis (CANN.C) releases Q2, 2020 financials
Gross revenue was $1.4-million in the second quarter of 2020, compared with nil in the three-month period ended April 30, 2019.
-
MedMen (MMEN.C): The Kings of Cannabis are dead but the stink remains
“In a sector rife with terrible CEOs that have wasted company treasury and goodwill…none come close to Bierman in terms of self enrichment, entitlement, and outward facing douchery,” wrote Chris Parry on January 31, 2020.
-
Plus Products (PLUS.C) just parachuted right into my world
Heimark has a track record of rigorous market research prior to launching products. This research-based approach has reaped dividends in market penetration and revenue growth.
-
![Vext Science (VEXT.C) enters California market and records a COVID-19 era loss of only $1 million]()
Vext Science (VEXT.C) enters California market and records a COVID-19 era loss of only $1 million
If you stop and think about it, the fact that Vext Science (VEXT.C) only lost USD$1 million in Q1 of 2020 is fantastic. Today’s news, of their joint operation with Green Goblin Inc. of San Diego, California, for extraction, distillation and kitchen operations today is only of moderate importance. Granted, it’s the next natural step…
